Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer (Q39216992)

10 September 2017

title

Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer (English)

1 reference

10 September 2017

0 references

0 references

Marwa I Shabayek

1 reference

10 September 2017

Ola M Sayed

1 reference

10 September 2017

Hanan A Attaia

1 reference

10 September 2017

Heba A Awida

1 reference

10 September 2017

Hamdy Abozeed

1 reference

10 September 2017

publication date

3 April 2014

1 reference

Pathology and Oncology Research

10 September 2017

published in

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

859-866

1 reference

Bladder cancer and schistosomiasis

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

The changing patterns of bladder cancer in Egypt over the past 26 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

Urinary bladder cancer risk factors in Egypt: a multicenter case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

Epidemiology and risk factors of urothelial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

Antiplasmin activity of a peptide that binds to the receptor-binding site of angiogenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

HIFs, angiogenesis, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

Expression of multiple forms of clusterin during light-induced retinal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

Synthesis and functional analyses of nuclear clusterin, a cell death protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

Human nuclear clusterin mediates apoptosis by interacting with Bcl-XL through C-terminal coiled coil domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12253-014-9765-Y

Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer

21 January 2018

1 reference

12 December 2020

Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma

1 reference

12 December 2020

Angiogenin-mediated rRNA transcription in cancer and neurodegeneration

1 reference

12 December 2020

Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder

1 reference

12 December 2020

Diagnostic evaluation of apoptosis inhibitory gene and tissue inhibitor matrix metalloproteinase-2 in patients with bladder cancer

1 reference

12 December 2020

Evaluation of serum and urine clusterin as a potential tumor marker for urinary bladder cancer

1 reference

12 December 2020

Biomarkers for detection and surveillance of bladder cancer.

1 reference

12 December 2020

10.1007/S12253-014-9765-Y

Identifiers

DOI

1 reference

10 September 2017

1 reference